Global epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis

Глобальная эпидемиология бокового амиотрофического склероза: систематический обзор и метаанализ
Bei Cao, Wei‐Ming Su, Qing‐Qing Duan, Yong‐Ping Chen, Ruyin Liu, Xi Wen, Sheng-Yi He, Nan Zhang
2026-07-03

amyotrophic lateral sclerosisdisease burdenglobal epidemiologymeta-analysissystematic review
Background Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with the global epidemiological profile remaining incompletely understood. While previous systematic reviews existed, an updated comprehensive synthesis is needed to delineate the disease burden. Methods We searched PubMed, Embase, Scopus, Web of Science and Cochrane databases from inception to 18 February 2025, for studies reporting the incidence, prevalence or mortality of ALS in the general population. Pooled estimates with 95% CIs were calculated, and subgroup analyses were performed. Results Of 29 110 articles initially screened, 142 were included. Global pooled incidence was 1.65 per 100 000 person-years (95% CI 1.43 to 1.91), prevalence was 5.05 per 100 000 population (95% CI 4.26 to 5.99) and mortality was 1.26 per 100 000 person-years (95% CI 0.94 to 1.69). Both incidence rate ratio (IRR=0.74) and prevalence rate ratio (PRR=0.69) indicated significantly lower disease burden in females than in males. The burden of disease exhibited a marked age-dependent pattern, peaking at ages 70–79. Temporal trend analyses revealed a consistent increase in prevalence from 1963 to 1999 onwards, while incidence peaked in 2014–2017. Geographically, incidence and prevalence were highest in Europe, North America and Oceania and lowest in Asia and South America. The disease burden was significantly higher in high-income countries compared with both upper-middle-income and lower-middle-income countries. Conclusion This systematic review provides updated global ALS burden estimates, showing variations by sex, age, time and geography and underscoring the complex interplay of genetic, environmental and socioeconomic factors, with implications for health planning, resource allocation and etiological research.
1
A systematic review of 142 studies estimated global ALS incidence at 1.65 per 100,000 person-years, prevalence at 5.05 per 100,000, and mortality at 1.26 per 100,000 person-years.
2
ALS burden increased markedly with age and peaked among people aged 70–79 years.
3
ALS incidence and prevalence were significantly lower in females than males, with incidence rate ratio 0.74 and prevalence rate ratio 0.69.
4
Incidence and prevalence were highest in Europe, North America, and Oceania, lowest in Asia and South America, and significantly greater in high-income countries.
5
Prevalence consistently increased from 1963 onward, whereas incidence reached its peak during 2014–2017.

amyotrophic lateral sclerosis (ALS) in the general population worldwide

global epidemiological burden of ALS, including incidence, prevalence, mortality, and their variation by sex, age, time, geography, and income level

Publication Details
Publication Date
2026-07-03
Journal
Publisher
ISSN
Cited by
7
Access Type
Author Information
Authors
Bei Cao
Wei‐Ming Su
Qing‐Qing Duan
Yong‐Ping Chen
Ruyin Liu
Xi Wen
Sheng-Yi He
Nan Zhang
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%